Correlation Between Merck KGaA and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck KGaA and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck KGaA and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck KGaA ADR and Medipharm Labs Corp, you can compare the effects of market volatilities on Merck KGaA and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck KGaA with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck KGaA and Medipharm Labs.

Diversification Opportunities for Merck KGaA and Medipharm Labs

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Merck and Medipharm is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Merck KGaA ADR and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Merck KGaA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck KGaA ADR are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Merck KGaA i.e., Merck KGaA and Medipharm Labs go up and down completely randomly.

Pair Corralation between Merck KGaA and Medipharm Labs

Assuming the 90 days horizon Merck KGaA ADR is expected to under-perform the Medipharm Labs. But the pink sheet apears to be less risky and, when comparing its historical volatility, Merck KGaA ADR is 2.51 times less risky than Medipharm Labs. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Medipharm Labs Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  6.00  in Medipharm Labs Corp on August 26, 2024 and sell it today you would lose (1.00) from holding Medipharm Labs Corp or give up 16.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Merck KGaA ADR  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Merck KGaA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck KGaA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Medipharm Labs Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward indicators, Medipharm Labs is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Merck KGaA and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck KGaA and Medipharm Labs

The main advantage of trading using opposite Merck KGaA and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck KGaA position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Merck KGaA ADR and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format